India Life Sciences Fund II, which focuses on growth capital in the Indian healthcare sector, has invested INR 40 Crore for a ‘significant minority’ stake in Oasis Centre for Reproductive Medicine, a Hyderabad-headquartered leading chain of in-vitro fertilisation (IVF) centres.